WALD
Waldencast plc
NASDAQ · Technology · Software - Application · US
$1.37
+0.00%Jul 30, 2026, 20:30 UTC
Waldencast completed the sale of its Obagi Medical business to Bridgepoint for up to $460 million.
Source:Jul 27, 2026, 17:59 UTC
Waldencast Plc filed a lawsuit in Delaware's Chancery Court against former Obagi CEO Jaime Castle and former parent Cedarwalk Skincare Ltd., alleging a channel-stuffing scheme that inflated Obagi's earnings by $50 million and caused Waldencast to overpay by hundreds of millions of dollars.
Source:Jun 15, 2026, 13:00 UTC
The FDA approved Obagi saypha ChIQ injectable hyaluronic acid gel for Obagi Medical, a brand of Waldencast plc.
Source:Jun 1, 2026, 10:59 UTC
Waldencast plc agreed to sell its Obagi Medical business to Bridgepoint for up to $460 million.
Source: